Prenatal Organoids Pave the Way for Personalized Medicine in Fetal Care
A recent review highlights the potential of prenatal organoids in advancing personalized medicine for fetal care. Organoids, which are three-dimensional structures derived from stem cells, can mimic the microarchitecture of human tissues. This technology is being applied to fetal medicine, offering new avenues for disease modeling, drug testing, and regenerative therapies. The review discusses the use of organoids derived from prenatal sources like amniotic fluid to study fetal diseases such as congenital diaphragmatic hernia and myelomeningocele. These organoids provide a unique bridge between in vitro approaches and personalized fetal medicine, potentially improving diagnosis, prognosis, and treatment strategies.